Lung- och allergimottagningen, Vrinnevisjukhuset
Norrköping, Östergötland County, 603 79, Sweden
Location status: Recruiting
NCT Number: NCT06891677
The goal of this clinical trial is to learn if an internet-based cognitive behavioral therapy (CBT) and education program can help improve mental health, disease knowledge, and quality of life in adults with chronic obstructive pulmonary disease (COPD). This is a feasibility study, meaning researchers want to find out if this online treatment program is practical, acceptable, and effective enough to use in a larger future study.
The main questions it aims to answer are:
Can internet-based CBT and disease education help participants feel less anxious, depressed, or stressed? Can this online program help participants better manage COPD symptoms and improve their quality of life? How easy and acceptable do participants find the online CBT and educational program?
Researchers will measure the following outcomes to see how well the program works:
Quantitative outcomes (using questionnaires and tests):
Depression symptoms (using Patient Health Questionnaire-9, PHQ-9) Anxiety symptoms (using Generalized Anxiety Disorder-7, GAD-7) Stress levels (using Perceived Stress Scale, PSS) Quality of life related to COPD (using St. George's Respiratory Questionnaire, SGRQ, and EuroQol-5 Dimensions, EQ5D) COPD-specific symptoms and impact on daily life (using COPD Assessment Test, CAT) Breathlessness severity during daily activities (using Modified Medical Research Council Dyspnea Scale, MRC) Physical capacity (using a 6-minute walk test) Lung function (using spirometry, a breathing test)
Qualitative outcomes (using interviews):
Participants' experiences and satisfaction with the internet-based therapy and education What participants think helps or hinders them from engaging with the online program How the program affects participants' daily lives and how they cope with COPD
Participants in the study will:
Take part in an internet-based CBT and education program designed specifically for COPD lasting 8-10 weeks. They can complete the program from home.
Answer questionnaires about mental health, stress, quality of life, COPD symptoms, and breathlessness before and after completing the program.
Visit the clinic two times (before and after the program) for breathing tests (spirometry) and physical capacity tests (6-minute walking test).
Some participants (10-15) will also participate in an interview to discuss their experiences and how they feel about the online treatment program.
The results of this study will help researchers understand whether internet-based CBT and COPD education is helpful and practical enough to study in a larger clinical trial in the future.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Norrköping, Östergötland County, 603 79, Sweden
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants receive an internet-based cognitive behavioral therapy (CBT) intervention combined with education specifically developed for COPD. The CBT program includes Acceptance and Commitment Therapy (ACT) components. The intervention lasts 8-10 weeks and consists of several online modules. Modules cover topics such as coping strategies, mindfulness techniques, disease knowledge, and symptom management. Participants complete the modules at home via a secure online platform, with regular support and feedback from trained healthcare professionals. The program aims to improve mental health, reduce anxiety and depression, enhance COPD knowledge, and help participants manage symptoms and daily life more effectively.
Other names: Internet-based CBT, Online CBT, Internet CBT, Acceptance and Commitment Therapy, Educational intervention for COPD
Time frame: At completion of the intervention (8-10 weeks)
Feasibility is measured by participant adherence (how many complete at least 75% of the online program), acceptability (participant satisfaction through questionnaires and interviews), and recruitment rate (how quickly participants join the study). High feasibility means that participants find the intervention practical, acceptable, and manageable, indicating it could be used in a larger clinical trial.
Time frame: Baseline (before intervention) and immediately after completing the intervention (8-10 weeks)
Participants' symptoms of depression will be measured using the Patient Health Questionnaire-9 (PHQ-9). This is a 9-item questionnaire that measures depression severity, with scores ranging from 0 (no depression) to 27 (severe depression). Researchers will assess if depression symptoms decrease after participants complete the internet-based CBT and educational intervention.
Time frame: Baseline and after completing the intervention (8-10 weeks)
Anxiety is measured with the Generalized Anxiety Disorder-7 questionnaire, scoring from 0 (no anxiety) to 21 (severe anxiety). Lower scores after intervention indicate improvement.
Time frame: Baseline and immediately after completing the intervention (8-10 weeks)
COPD-specific quality of life is measured using the St. George's Respiratory Questionnaire (SGRQ). Scores range from 0 to 100, with lower scores meaning better quality of life and fewer COPD symptoms.
Time frame: Baseline and after the intervention (8-10 weeks)
General quality of life is measured with EuroQol-5 Dimensions (EQ5D). The EQ5D evaluates general health status across five domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Higher scores indicate better quality of life.
Time frame: Baseline and after intervention completion (8-10 weeks)
COPD symptoms and their impact on daily activities are measured using the COPD Assessment Test (CAT). Scores range from 0 to 40, where lower scores mean fewer COPD-related symptoms and problems.
Time frame: Baseline and immediately after completing the intervention (8-10 weeks)
Breathlessness during everyday activities is measured with the Modified Medical Research Council Dyspnea Scale (MRC). Scores range from 0 (breathless only during heavy exertion) to 4 (too breathless to leave the house). Lower scores after the intervention indicate improvement.
Time frame: Baseline and after completing the intervention (8-10 weeks)
Stress levels are measured using the Perceived Stress Scale (PSS-10), with scores ranging from 0 (no stress) to 40 (high stress). The goal is to see if the intervention reduces participants' perceived stress.
Time frame: Baseline and after intervention (8-10 weeks)
Physical capacity is measured with a 6-minute walk test (6MWT). Researchers measure how far participants can walk in six minutes, in meters, before and after the intervention to see if participants' physical ability improves.
Time frame: Baseline and immediately after completing the intervention (8-10 weeks)
Lung function is measured using spirometry, testing forced expiratory volume in one second (FEV1) and forced vital capacity (FVC).
Time frame: At completion of intervention (8-10 weeks)
Participants' experiences, satisfaction, and perceived impact of the online intervention are assessed through qualitative interviews. Researchers aim to understand participant views about barriers, benefits, and the intervention's impact on daily life.
Contact information is provided by the study sponsor or research team.
Jonas Agholme
Other
COPD BALANCE: A Feasibility Study of Internet-Based Cognitive Behavioral Therapy and Educational Intervention to Improve Mental Health, Disease Knowledge, and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease
Acronym: COPD BALANCE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06782724
ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis
Prague, Czechia
View Trial DetailsNCT07363980
Anxiety Disorders, Arthritis
Aarhus, Denmark
View Trial DetailsNCT06958666
COPD (Chronic Obstructive Pulmonary Disease), Chronic Disease
Hangzhou, Zhejiang, China
View Trial DetailsNCT07704567
COPD (Chronic Obstructive Pulmonary Disease), Chronic Disease
Denver, Colorado, United States
View Trial Details